Author

Michael Gleimer

Observed name: M Gleimer

Observed institutions: Harvard University, University of Michigan, Dana-Farber Cancer Institute, Stanford Medicine, Stanford University

OpenAlex ID: A5025381054

Continuous T cell receptor signaling required for synapse maintenance and full effector potential

2003 · Johannes B Huppa, Michael Gleimer, et al. · Nature Immunology · 403

Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3

2008 · Achim K Moesta, Paul J Norman, et al. · The Journal of Immunology · 386

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C

2009 · Thorsten Graef, Achim K. Moesta, et al. · The Journal of Experimental Medicine · 245

Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans

2007 · Paul J Norman, Laurent Abi-Rached, et al. · Nature Genetics · 218

The Protein Made from a Common Allele of KIR3DL1 ( 3DL1*004 ) Is Poorly Expressed at Cell Surfaces due to Substitution at Positions 86 in Ig Domain 0 and 182 in Ig Domain 1

2003 · Marcelo J Pando, Clair M Gardiner, et al. · The Journal of Immunology · 215

Stress Management

2003 · Michael Gleimer, Peter Parham · Immunity · 121

β-Selection-Induced Proliferation Is Required for αβ T Cell Differentiation

2012 · Taras Kreslavsky, Michael Gleimer, et al. · Immunity · 93

αβ versus γδ fate choice: counting the T‐cell lineages at the branch point

2010 · Taras Kreslavsky, Michael Gleimer, et al. · Immunological Reviews · 77

Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I

2004 · Monia Draghi, Nobuyo Yawata, et al. · Blood · 59

PLZF Controls the Expression of a Limited Number of Genes Essential for NKT Cell Function

2012 · Michael Gleimer, Harald von Boehmer, et al. · Frontiers in Immunology · 54

Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes

2014 · M Gleimer, Y Li, et al. · Bone Marrow Transplantation · 45

αβ versus γδ lineage choice at the first TCR-controlled checkpoint

2010 · Taras Kreslavsky, Michael Gleimer, et al. · Current Opinion in Immunology · 43

Although Divergent in Residues of the Peptide Binding Site, Conserved Chimpanzee Patr-AL and Polymorphic Human HLA-A*02 Have Overlapping Peptide-Binding Repertoires

2011 · Michael Gleimer, Angela R Wahl, et al. · The Journal of Immunology · 29

Identification of a germ-line pro-B cell subset that distinguishes the fetal/neonatal from the adult B cell development pathway

2002 · Li-Sheng Lu, James Tung, et al. · Proceedings of the National Academy of Sciences · 28

A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule

2015 · Ana Goyos, Lisbeth A Guethlein, et al. · The Journal of Immunology · 11

Thymocyte Selection: Chemokine Signaling Is Not Only about the Destination

2010 · Michael Gleimer, Harald von Boehmer · Current Biology · 6

Baseline Body Mass Index Among Children and Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: Clinical Characteristics and Outcomes

2014 · Michael Gleimer, Yumeng Li, et al. · Blood · 1

Works count: 20

Citation count: 2,034

H-index: 14

I10-index: 15